• SENSEX
    NIFTY 50
Healthcare

Cadila receives tentative USFDA nod for Apremilast tablets

Updated : November 18, 2019 08:22 AM IST

The company has received the tentative approval from the USFDA to market the tablets in the strengths of 10 mg, 20 mg, and 30 mg.
With this, the group now has 276 approvals.
Cadila receives tentative USFDA nod for Apremilast tablets

You May Also Like

Live TV
Advertisement